Skip to main navigation

English
Français

IR Navigation

Overview
News
Events & Presentations
- Events
- Presentations
Stock Information
Financials
Governance
Resources

Press Releases

Press Releases

Items Per Page

Year

27 May 2020

GENFIT: Publication of the 2019 Universal Registration Document and the 2019 Annual Report on Form 20-F

18 May 2020

GENFIT: Reports First Quarter 2020 Financial Information

11 May 2020

GENFIT: Announces Results from Interim Analysis of RESOLVE-IT Phase 3 Trial of Elafibranor in Adults with NASH and Fibrosis

07 May 2020

GENFIT: Annual Shareholders Meeting of June 11, 2020 – Availability of Preparatory Documents

29 Apr 2020

GENFIT: Updates to 2020 Financial Calendar

08 Apr 2020

GENFIT Reports Full-Year 2019 Financial Results and Corporate Update

31 Mar 2020

GENFIT: Update on Regulatory and Clinical Activities Amid the COVID-19 Pandemic

20 Feb 2020

GENFIT: Unblinding of Phase 3 RESOLVE-IT Data Deferred

21 Jan 2020

GENFIT: 2020 Financial Calendar

10 Jan 2020

GENFIT: 2019 Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial

Pagination

First page
Previous page
Page 1
Current page 2

Displaying 11 - 20 of 20

Shareholder Tools

Print Page
Email Alerts
RSS
Contact IR

Request E-mail Alerts

GENFIT Headquarters
Parc Eurasanté 885, Avenue Eugène Avinée 59120 Loos France GENFIT Corp
1 Alewife Center Suite 220 Cambridge MA 02140 USA

All rights reserved.